Denali Therapeutics Receives 2026 Prix Galien USA Award for AVLAYAH® (tividenofusp alfa-eknm) as Best Biotechnology ProductGlobeNewsWire • 5h
Denali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026GlobeNewsWire • 10/22/26
Denali Therapeutics Inc. (DNLI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/14/26
DNLI Stock Gains 33.1% in Three Months: Buy, Sell or Hold the Stock?Zacks Investment Research • 08/20/26
Denali Therapeutics Inc. (DNLI) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research • 08/06/26
Denali Therapeutics Reports Second Quarter 2026 Financial Results and Business HighlightsGlobeNewsWire • 08/06/26
Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026GlobeNewsWire • 07/27/26
Denali Therapeutics to Give Opening Plenary Address at Alzheimer's Association International Conference (AAIC) 2026 and Highlight Breakthroughs in Delivering Biologic Therapies Across Blood-Brain BarrierGlobeNewsWire • 07/09/26
DNLI Stock Surges 59.4% Year to Date: Is There More Room for Growth?Zacks Investment Research • 07/08/26
Denali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 MillionGlobeNewsWire • 06/18/26
Denali Therapeutics Inc. (DNLI) Presents at Jefferies Global Healthcare Conference 2026 TranscriptSeeking Alpha • 06/05/26
Denali Therapeutics: 'Strong Buy' On AVLAYAH Approval And End Of 2026 FTD-GRN DataSeeking Alpha • 05/27/26
Denali Stock Dips as Biogen-Partnered Parkinson's Disease Study FailsZacks Investment Research • 05/22/26
Denali Therapeutics Says AVLAYAH Launch Ahead of Expectations After Hunter Syndrome ApprovalMarketBeat • 05/16/26
Denali Therapeutics Inc. (DNLI) Presents at Bank of America Global Healthcare Conference 2026 TranscriptSeeking Alpha • 05/13/26
DNLI Q1 Loss Narrower Than Expected, Avlayah Approval Boosts ProspectsZacks Investment Research • 05/08/26
Denali Therapeutics Reports First Quarter 2026 Financial Results and Business HighlightsGlobeNewsWire • 05/07/26